aaekipolo.blogspot.com
Hematide is in a Phase III Renton led Onyx for nearly15 years, stepping down in Februaruy 2008 as president, CEO, chairmam and a member of Onyx’s At the company, he helpesd negotiate a research, development and commercializatio n partnership with that resulted in the anti-cancer drug Nexavar. Nexavar tablets, which cost about $5,00p0 a month in the Unitedc States and areapproachingv $1 billion in annual sales, are approved in more than 80 countriexs to treat kidney canceer and 70-plus countries for liver Prior to joining Onyx, Renton was presidenr and COO of Chiron, which acquired Cetuw in 1991. Renton had been president of Cetuswsince 1990, COO since 1987 and CFO from 1983 to 1987.
Rentohn also serves on the boardsof , Cepheidd and the Special Olympics of Northern
No comments:
Post a Comment